Institute for Glycomics

Institute for Glycomics

Established in 2000, through investment from Griffith University and the Queensland State Government, the Institute for Glycomics strive to be world leaders in developing next generation drugs, vaccines and diagnostics for diseases of global impact.

The Institute for Glycomics’ advantage is their focused approach towards drug, vaccine and diagnostic technology discovery and development using world-leading scientific expertise and dedication to discovering preventions and cures for a number of human diseases including infectious diseases and cancers.

The Institute boasts some of the world’s most renowned research leaders and state-of-the-art facilities. This rich research environment provides exceptional postgraduate education programs for the nation’s future scientists.

Principal research areas

  • Cancer research program
  • Infectious disease research program

Director

Professor Mark von Itzstein

Chair

The Hon Robert Borbidge